TORONTO, June 20, 2016 /CNW/ - Bedrocan Canada Inc.
(Bedrocan Canada), wholly owned subsidiary of Canopy Growth
Corporation (Canopy Growth) (TSXV: CGC) has received its Health
Canada license to sell cannabis oils in addition to dried cannabis
products. Three varieties are available for sale today with the
remaining three standardized Bedrocan varieties following
shortly.
New bedro-oils are made by extracting oils from Bedrocan
Canada's line of standardized whole-flower cannabis varieties using
CO2 supercritical extraction equipment. Once the crude
extraction is purified, it is balanced with organic sunflower oil
to create a versatile product that can be consumed on its own or
used for baking or cooking.
"Many of our clients have expressed a desire to ingest cannabis
oils to either compliment or substitute the inhaled route," said
Marc Wayne, President, Bedrocan
Canada. "We're proud to offer this new option for patients who,
whether for convenience or for health reasons, prefer to ingest
their medical cannabis."
Along with Bedrocan Canada's sister company, Tweed Inc., the
company has committed $50,000 toward
partnerships with leading organizations committed to responsible
use education. $1 from every bottle
of 10:1 bedro-oils sold will also go towards important
initiatives such as a recently announced partnership with MADD
Canada and the Canadian Drug Policy Coalition.
Keeping with Bedrocan Canada's commitment to True
Compassionate Pricing, bedro-oils will be sold for
$110 per 100ml bottle.
About Bedrocan Canada
Bedrocan Canada is focused on medicinal cannabis production and
research, including, the EQUAL Study, which is currently enrolling
patients and evaluating how cannabis is affecting their quality of
life of Canadian patients. Bedrocan's standardized strains have
been used by thousands of patients in seven countries around the
world. www.bedrocan.ca
About Canopy Growth Corporation
Canopy Growth is Canada's first publicly traded medical
marijuana company and the first geographically diversified producer
with multiple licenses under the Marihuana for Medical Purposes
Regulations. Through its wholly owned subsidiaries, Tweed, Tweed
Farms, and Bedrocan Canada, the Company operates three
state-of-the-art production facilities in Ontario and
distributes marijuana across the country to Canadian patients
managing a host of medical conditions. The Company is dedicated to
educating healthcare practitioners, providing consistent access to
high quality medication, conducting robust clinical research, and
furthering the public's understanding of how marijuana is used for
medical purposes. www.canopygrowth.com
Forward Looking Statement
This news release contains forward-looking statements. Often,
but not always, forward-looking statements can be identified by the
use of words such as "plans", "expects" or "does not expect", "is
expected", "estimates", "intends", "anticipates" or "does not
anticipate", or "believes", or variations of such words and phrases
or state that certain actions, events or results "may", "could",
"would", "might" or "will" be taken, occur or be achieved.
Forward-looking statements involve known and unknown risks,
uncertainties and other factors which may cause the actual results,
performance or achievements of the Company or any of its
subsidiaries to be materially different from any future results,
performance or achievements expressed or implied by the
forward-looking statements.
Although Canopy Growth Corp. has attempted to identify important
factors that could cause actual actions, events or results to
differ materially from those described in forward-looking
statements, there may be other factors that cause actions, events
or results not to be as anticipated, estimated or intended. Readers
should not place undue reliance on forward-looking statements. The
factors identified above are not intended to represent a complete
list of the factors that could affect the Company or any of its
subsidiaries. The forward-looking statements included in this news
release are made as of the date of this news release and Canopy
Growth Corp. does not undertake an obligation to publicly update
such forward-looking statements to reflect new information,
subsequent events or otherwise unless required by applicable
securities legislation.
SOURCE Canopy Growth Corporation